Clinical relevance of amphiregulin and VEGF in primary breast cancers

This publication has 39 references indexed in Scilit:

• Vascular Endothelial Growth Factor, Transforming Growth Factor-α, and Estrogen Receptors: Possible Cross-Talks and Interactions
  The American Journal of Pathology, 2002
• Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications
  The Lancet Oncology, 2001
• Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β
  Proceedings of the National Academy of Sciences, 2000
• Clinical applications of angiogenic growth factors and their inhibitors
  Nature Medicine, 1999
• Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
  Molecular and Cellular Endocrinology, 1999
• Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
  Journal of Clinical Oncology, 1998
• Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
  Endocrinology, 1996
• Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma
  Journal of Biological Chemistry, 1996
• Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells
  Published by Elsevier ,1995
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
  Nature, 1992